StockData
BJDXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

Bluejay Diagnostics, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$0.70−0.05 (-6.46%)

Close on Oct 19, 2026

Market cap
$1.45M
P/E (TTM)
–
Dividend yield
–

Earnings

Quarterly results announced on Form 8-K, Item 2.02

QuarterReportedTimeRevenueEPS (GAAP)EPS (adjusted)
Q1 FY2026
Ended Mar 31, 2026
May 7, 2026After market close–––
Q4 FY2025
Ended Dec 31, 2025
Mar 6, 2026Before market open–––
Q3 FY2023
Ended Sep 30, 2023
Nov 9, 2023After market close–$-2.08–
Q2 FY2023
Ended Jun 30, 2023
Aug 16, 2023Before market open–$-2.75–
Q1 FY2023
Ended Mar 31, 2023
May 10, 2023During market hours–$-0.12–
Q4 FY2022
Ended Dec 31, 2022
Mar 20, 2023After market close–––
Q3 FY2022
Ended Sep 30, 2022
Nov 8, 2022After market close–––
Q2 FY2022
Ended Jun 30, 2022
Jul 26, 2022During market hours–––
Q1 FY2022
Ended Mar 31, 2022
Apr 20, 2022After market close–––
Q4 FY2021
Ended Dec 31, 2021
Mar 10, 2022Before market open–––
Q3 FY2021
Ended Sep 30, 2021
Dec 16, 2021Before market open–––

Press releases

Announcements Bluejay Diagnostics filed with the SEC